Overall Status

Active, not recruiting (1)

Terminated (1)

Sign in for free

Phase

phase 2 (1)

phase 3 (1)

Sponsor

Celldex Therapeutics (1)

Gamida Cell ltd (1)

Collaborator

Intervention

cdx-301 (1)

cdx-301 and plerixafor (1)

cord blood unit (1)

nicord® (omidubicel) (1)

Study Documents

Intervention Type

drug (2)

other (1)

Funder Type

Industry (2)

Study Type

Interventional (2)

chronic myelogenous leukemia (cml)

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS